← Leaderboards
Myles A Brown
Dana-Farber Cancer Institute
$19,328,495
Attributed
$22,480,218
Total exposure
17
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,480,218 · 17
By mechanism
R01$9,694,178 · 5
P01$9,377,756 · 7
P50$2,988,178 · 4
R56$420,106 · 1
Top collaborators
- Matthew L Freedman5 shared
- Mark M. Pomerantz5 shared
- Xiaole Shirley Liu3 shared
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Alan N. Engelman$40,161,770
- Emmett Vance Schmidt$8,396,491
- Ian E Krop$2,869,815
- Thomas M Roberts$29,815,975
- Sandy S Chang$11,703,226
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesPlayProgramsCellsMediatingTranscription FactorGene ExpressionSiteAndrogen ReceptorSignal TransductionGenome-WideGene TargetingGrowthMalignant Breast NeoplasmAndrogensNew Therapeutic TargetEnhancersReceptor SignalingEpigenetic ProcessMalignant NeoplasmsEstrogen ReceptorsEstrogensTumorTumor Progression
Grant awards (64)
Functional Interplay Between PARP, AR and DNA Damage$331,742
P01 · FY2025 · CA · contact PI
Development Research Program$137,815
P50 · FY2025 · CA · contact PI
Targeting Mechanisms of Endocrine Resistance in Breast Cancer$283,987
P01 · FY2024 · CA · contact PI
Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC$370,664
P01 · FY2023 · CA · contact PI
Targeting Mechanisms of Endocrine Resistance in Breast Cancer$340,801
P01 · FY2023 · CA · contact PI
Regulators of Cancer Immunotherapy Response$598,991
R01 · FY2022 · CA · contact PI
Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC$370,489
P01 · FY2022 · CA · contact PI
Targeting Mechanisms of Endocrine Resistance in Breast Cancer$340,801
P01 · FY2022 · CA · contact PI
Regulators of Cancer Immunotherapy Response$604,374
R01 · FY2021 · CA · contact PI
Targeting Mechanisms of Endocrine Resistance in Breast Cancer$347,755
P01 · FY2021 · CA · contact PI
Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC$341,767
P01 · FY2021 · CA · contact PI
Targeting Mechanisms of Endocrine Resistance in Breast Cancer$357,880
P01 · FY2020 · CA · contact PI
Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC$341,767
P01 · FY2020 · CA · contact PI
Defining the epigenetic landscape in human prostate cancer$582,787
R01 · FY2019 · CA
Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC$360,516
P01 · FY2019 · CA · contact PI
Defining the epigenetic landscape in human prostate cancer$600,812
R01 · FY2018 · CA
Epigenetics of Hormone Signaling in Breast Development and Cancer$301,571
P01 · FY2018 · CA · contact PI
Large-Scale In Vivo Functional Characterization of the Human Cistrome$734,988
R01 · FY2017 · HG · contact PI
Defining the epigenetic landscape in human prostate cancer$633,613
R01 · FY2017 · CA
Epigenetic Reprogramming of AR Function in CRPC$338,039
P01 · FY2017 · CA · contact PI
Epigenetics of Hormone Signaling in Breast Development and Cancer$301,671
P01 · FY2017 · CA · contact PI
Androgens, Androgen Receptor Signaling and Breast Carcinogenesis$188,910
P50 · FY2017 · CA · contact PI
Large-Scale In Vivo Functional Characterization of the Human Cistrome$734,988
R01 · FY2016 · HG · contact PI
Defining the epigenetic landscape in human prostate cancer$628,587
R01 · FY2016 · CA
Epigenetic Reprogramming of AR Function in CRPC$338,022
P01 · FY2016 · CA · contact PI
Epigenetics of Hormone Signaling in Breast Development and Cancer$301,581
P01 · FY2016 · CA · contact PI
Androgens, Androgen Receptor Signaling and Breast Carcinogenesis$223,466
P50 · FY2016 · CA · contact PI
Large-Scale In Vivo Functional Characterization of the Human Cistrome$734,288
R01 · FY2015 · HG · contact PI
Defining the epigenetic landscape in human prostate cancer$628,587
R01 · FY2015 · CA
Epigenetic Reprogramming of AR Function in CRPC$370,667
P01 · FY2015 · CA · contact PI
Epigenetics of Hormone Signaling in Breast Development and Cancer$259,114
P01 · FY2015 · CA · contact PI
Androgens, Androgen Receptor Signaling and Breast Carcinogenesis$214,649
P50 · FY2015 · CA · contact PI
Epigenetic Reprogramming of AR Function in CRPC$327,657
P01 · FY2014 · CA · contact PI
Androgens, Androgen Receptor Signaling and Breast Carcinogenesis$283,676
P50 · FY2014 · CA · contact PI
Epigenetics of Hormone Signaling in Breast Development and Cancer$265,696
P01 · FY2014 · CA · contact PI
Epigenetic Reprogramming of AR Function in CRPC$360,869
P01 · FY2013 · CA · contact PI
Androgens, Androgen Receptor Signaling and Breast Carcinogenesis$314,812
P50 · FY2013 · CA · contact PI
Recruitment of Stromal Cells to Mammary Tumors$235,070
P01 · FY2013 · CA · contact PI
Recruitment of Stromal Cells to Mammary Tumors$252,197
P01 · FY2012 · CA · contact PI
Comprehensive Analysis of Estrogen Receptor Genomic Action$567,101
R01 · FY2011 · DK · contact PI
P-5: The Androgen Receptor in Hormone Refractory Disease$271,799
P50 · FY2011 · CA · contact PI
Recruitment of Stromal Cells to Mammary Tumors$254,474
P01 · FY2011 · CA · contact PI
Comprehensive Analysis of Estrogen Receptor Genomic Action$580,656
R01 · FY2010 · DK · contact PI
P-5: The Androgen Receptor in Hormone Refractory Disease$286,104
P50 · FY2010 · CA · contact PI
Estrogen Signaling in Breast Development and Cancer$264,362
P01 · FY2010 · CA · contact PI
Comprehensive Analysis of Estrogen Receptor Genomic Action$82,284
R01 · FY2010 · DK · contact PI
Comprehensive Analysis of Estrogen Receptor Genomic Action$567,691
R01 · FY2009 · DK · contact PI
Estrogen Signaling in Breast Development and Cancer$265,464
P01 · FY2009 · CA · contact PI
The Androgen Receptor in Hormone Refractory Disease$224,041
P50 · FY2009 · CA · contact PI
Comprehensive Analysis of Estrogen Receptor Genomic Action$554,155
R01 · FY2008 · DK · contact PI
Estrogen Signaling in Breast Development and Cancer$248,532
P01 · FY2008 · CA · contact PI
The Androgen Receptor in Hormone Refractory Disease$224,043
P50 · FY2008 · CA · contact PI
Comprehensive Analysis of Estrogen Receptor Genomic Action$572,709
R01 · FY2007 · DK · contact PI
Estrogen Signaling in Breast Development and Cancer$248,566
P01 · FY2007 · CA · contact PI
The Androgen Receptor in Hormone Refractory Disease$223,861
P50 · FY2007 · CA · contact PI
P-3: Role of Coregulators in Response to Aromatase Inhibitors$172,933
P50 · FY2007 · CA · contact PI
Comprehensive Analysis of Estrogen Receptor Genomic Action$420,106
R56 · FY2006 · DK · contact PI
Estrogen Signaling in Breast Development and Cancer$223,112
P01 · FY2006 · CA · contact PI
P-3: Role of Coregulators in Response to Aromatase Inhibitors$111,067
P50 · FY2006 · CA · contact PI
Estrogen Signaling in Breast Development and Cancer$219,103
P01 · FY2005 · CA
P-3: Role of Coregulators in Response to Aromatase Inhibitors$111,002
P50 · FY2005 · CA
Estrogen Signaling in Breast Development and Cancer$213,820
P01 · FY2004 · CA
FUNCTIONS OF ESTROGEN RECEPTOR ASSOCIATED PROTEINS$25,519
R01 · FY2001 · CA
FUNCTIONS OF ESTROGEN RECEPTOR ASSOCIATED PROTEINS$262,048
R01 · FY2000 · CA